Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05668923 · ClinicalTrials.gov registry record · NA
Speech Signals in Stuttering
A NA study of Stuttering, Childhood, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT05668923: Recruiting NA study of Stuttering, Childhood, sponsored by University of Pittsburgh.
NCT05668923 is a NA study of Stuttering, Childhood that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 600 participants, below the 769-participant average among 5 other Stuttering, Childhood trials with a reported enrollment target (22% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05668923, a NA study of Stuttering, Childhood, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to understand how speech and language are processed in the brain. This study will provide information that may help with the understanding how speech and language are processed in children and whether there may be differences between children who stutter and children who do not stutter. This project will evaluate these neural processes for speech signals in children who stutter and control subjects through a battery of behavioral speech and language tests, electroencephalography-based (EEG) tasks, functional magnetic resonance imaging (fMRI), and computational modeling.
Primary Outcome
Behavioral responses will be measured for the syllable identification task in quiet and in the presence of background noise. Children will respond as quickly as possible to identify which speech sound they heard. Within and between group analyses will be conducted between children who stutter and control subjects. Drift diffusion models (DDMs) will be used to aggregate the behavioral responses of accuracy and reaction time to evaluate bias toward more accurate or faster responses as well as chan
Conditions Studied
Interventions
- BEHAVIORAL Speech sound stimulation
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05668923 shows while recruiting
NCT05668923 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 769-participant average among 5 other Stuttering, Childhood trials with a reported enrollment target (22% lower).
The record links to 1 condition, with Stuttering, Childhood appearing as the primary indexed condition, and to 1 intervention - of which Speech sound stimulation is the first listed.
NCT05668923 reports a single indexed study location in Michigan, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05668923 about?
NCT05668923 is a clinical study titled "Speech Signals in Stuttering". The purpose of this research study is to understand how speech and language are processed in the brain. This study will provide information that may help with the understanding how speech and language are processed in children and whether there may be differences between children who stutter and chi...
What is the current status of trial NCT05668923?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2022-09-21. Estimated completion is 2027-12.
What conditions does trial NCT05668923 study?
This clinical trial studies the following conditions: Stuttering, Childhood.
What interventions are being tested in trial NCT05668923?
The interventions under investigation include: Speech sound stimulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05668923?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05668923 being conducted?
This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stuttering, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Alternating Current Stimulation (tACS) in Stuttering
RECRUITING · NA
-
Exploring the Nature, Assessment and Treatment of Stuttering
RECRUITING · NA
-
Network Connectivity and Temporal Processing in Adolescents Who Stutter
RECRUITING · NA
-
Speech Processing in Stuttering
COMPLETED · NA
-
The Development of Stuttering in Young Children
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI